Clinical Trial Update: Memantine add-on for Cognitive and Negative Symptoms of Schizophrenia [Phase 3]

View source ↗

Summary

An update on a Phase 3 clinical trial evaluating memantine added to standard treatment for cognitive and negative symptoms in schizophrenia. The current status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Memantine (memantine)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Schizophrenia | Phase 3 | Status: UNKNOWN